Daily Oncology News

ESMO: Herceptin may be best option for HER2 breast cancer treatment

ESMO: Herceptin may be best option for HER2+ breast cancer treatment

Drug should remain standard of care for HER2-positive tumors, according to new research.

ESMO: Combination treatments increase metastatic melanoma survival

ESMO: Combination treatments increase metastatic melanoma survival

Studies show improved progression-free melanoma survival for both cobimetinib combined with vemurafenib, and dabrafenib combined with trametinib.

Lung infections may lessen chance of detecting lung cancer

Lung infections may lessen chance of detecting lung cancer

Certain conditions make it harder to reliably detect tumors, and regions with locally-endemic infectious lung diseases pose an added hurdle for lung cancer detection.

Report identifies new directions for U.S. health care

Report identifies new directions for U.S. health care

A report from the IMS Institute for Healthcare Informatics notes 10 "harbingers of change" expected to alter the delivery of health care and medicine use over the next decade.

E-cigarettes don't help cancer patients stop smoking

E-cigarettes don't help cancer patients stop smoking

Smokers with cancer who used e-cigarettes along with traditional cigarettes were more dependent on nicotine, and the long-term safety of the devices still unclear, researchers caution.

Pancreatic cancer risk not increased with dipeptidyl-peptidase-4 inhibitors (DPP-4i)

Pancreatic cancer risk not increased with dipeptidyl-peptidase-4 inhibitors (DPP-4i)

Findings based on comparison to sulfonylureas and thiazolidinediones

Wild berry may up chemotherapy effectiveness for pancreatic cancer

Wild berry may up chemotherapy effectiveness for pancreatic cancer

Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line, according to research.

ASTRO: Sexual function not compromised in prostate cancer combo treatment

ASTRO: Sexual function not compromised in prostate cancer combo treatment

High rates of preserved sexual function seen with combination beam plus brachytherapy for prostate cancer.

Screening elderly women for breast cancer not efficacious

Screening elderly women for breast cancer not efficacious

Mammograms for those aged 69 to 75 could result in over-treatment, researchers caution.

AACR: Targeted drugs and prevention reduce cancer mortality

AACR: Targeted drugs and prevention reduce cancer mortality

About 14.5 million U.S. cancer survivors are alive today, but aging population and increasing obesity threaten progress.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs